Related Experiment Video
Updated: May 24, 2026

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
Published on: May 19, 2016
MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4
N Agarwal1, A S Adhikari, S V Iyer
1Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Abstract:
Murine double minute (MDM2) binding protein (MTBP) has been implicated in cancer progression. Here, we demonstrate one mechanism by which MTBP inhibits cancer metastasis. Overexpression of MTBP in human osteosarcoma cell lines lacking wild-type p53 did not alter primary tumor growth in mice, but significantly inhibited metastases. MTBP downregulation increased the migratory potential of MDM2(-/-)p53(-/-) mouse embryonic fibroblasts, suggesting that MTBP inhibited cell migration independently of the Mdm2-p53 pathway. Co-immunoprecipitation and mass spectrometric analysis identified alpha-actinin-4 (ACTN4) as an MTBP-interacting protein. Endogenous MTBP interacted with and partially colocalized with ACTN4. MTBP overexpression inhibited cell migration and filopodia formation mediated by ACTN4. Increased cell migration by MTBP downregulation was inhibited by concomitant downregulation of ACTN4. MTBP also inhibited ACTN4-mediated F-actin bundling. We furthermore demonstrated that nuclear localization of MTBP was dispensable for inhibiting ACTN4-mediated cell migration and filopodia formation. Thus, MTBP suppresses cell migration, at least partially, by inhibiting ACTN4 function. Our study not only provides a mechanism of metastasis suppression by MTBP, but also suggests MTBP as a potential biomarker for cancer progression.
Insights
Murine double minute (MDM2) binding protein (MTBP) inhibits cancer metastasis by targeting alpha-actinin-4 (ACTN4). MTBP suppresses cell migration and filopodia formation, suggesting its potential as a cancer progression biomarker.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Murine double minute (MDM2) binding protein (MTBP) is implicated in cancer progression.
- Understanding MTBP's role in metastasis is crucial for developing targeted therapies.
Purpose of the Study:
- To elucidate the mechanism by which MTBP inhibits cancer metastasis.
- To identify proteins interacting with MTBP and their functional relevance.
Main Methods:
- Overexpression and downregulation of MTBP in human osteosarcoma and mouse embryonic fibroblast cell lines.
- Co-immunoprecipitation and mass spectrometry to identify interacting proteins.
- Assessment of cell migration, filopodia formation, and F-actin bundling.
Main Results:
- MTBP overexpression inhibited metastasis in osteosarcoma models, independent of the Mdm2-p53 pathway.
- Alpha-actinin-4 (ACTN4) was identified as an MTBP-interacting protein.
- MTBP inhibited ACTN4-mediated cell migration, filopodia formation, and F-actin bundling.
Conclusions:
- MTBP suppresses cancer cell migration and metastasis by inhibiting ACTN4 function.
- MTBP's mechanism of action involves direct interaction with ACTN4, affecting cytoskeletal dynamics.
- MTBP is a potential biomarker for cancer progression and metastasis.
Related Concept Videos
Mechanism of Lamellipodia Formation
Mechanism of Filopodia Formation
Their main function is to guide migrating cells during normal tissue morphogenesis or cancer metastasis by recognizing and making initial contacts with the extracellular matrix. However, they can also act as stationary cell anchors or help to establish communication...
Cell Migration
Actin Treadmilling
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate.
Formation of Higher-order Actin Filaments
The high-order actin networks...

